Andrew J. Schwab - Insider Trading & Ownership

Entity
Individual
Location
C/O 5 Am Venture Management, Llc, 4 Embarcadero Center, Suite 3110, San Francisco, CA
Summary
The estimated net worth of Andrew J. Schwab is at least $74.6M dollars as of February 26, 2025. Andrew J. Schwab is the Director of Skye Bioscience, Inc. and owns shares of Skye Bioscience, Inc. (SKYE) stock worth about $60.1M. Andrew J. Schwab is the Director, 10%+ Owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $14.5M.
All Insider Reports
All Insider Reports

Ownership of Andrew J. Schwab

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SKYE Skye Bioscience, Inc. Director $60.1M -$1.75M -2.83% Feb 24, 2025
ELVN, IMRA Enliven Therapeutics, Inc. Director, 10%+ Owner $14.5M Feb 23, 2023
CAMP Camp4 Therapeutics Corp Director, 10%+ Owner Oct 15, 2024
PEARQ Pear Therapeutics, Inc. Director, 10%+ Owner Dec 3, 2021

Insider Transactions Reported by Andrew J. Schwab:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.